Evans V, Roderick P, Pollock AM. Adequacy of clinical trial evidence of metformin fixed-dose combinations for the treatment of type 2 diabetes mellitus in India. BMJ Global Health. 2018;3:e000263. download
Pollock AM, McGettigan P. Indian government not doing enough to tackle sale of unapproved antibiotics. The Conversation. 2017
McGettigan P, Roderick P, Kadam A, Pollock AM. Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship. The Lancet Global Health. 2017 Nov 1;5(11):e1075–6. download
Brhlikova P, Harper I, Subedi M, Bhattarai S, Rawal N, Pollock AM. Aid conditionalities, international Good Manufacturing Practice standards and local production rights: a case study of local production in Nepal. Globalization and Health. 11(25). download
Leng H, Sanders D, Pollock AM. Pro-generics policies and the backlog in medicines registration in South Africa: implications for access to essential and affordable medicines. GaBi Journal. 2015;4(2). download
Millard C, Brhlikova P, Pollock AM. Social networks and health policy: the case of misoprostol and the WHO model essential medicine list. Social Science & Medicine. 2015;132:190–6. download
McGettigan P, Roderick P, Mahajan R, Kadam A, Pollock, AM. Use of fixed dose combination (FDC) drugs in India: central regulatory approval and sales of FDCs containing non-steroidal anti-inflammatory drugs (NSAIDs), metformin, or psychotropic drugs. PLoS Med. 2015;12(5):e1001826. download
Atukunda EC, Brhlikova P, Agaba AG, Pollock AM. Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study. The Lancet. 2013;382(Supplement 1):10. download pdf
McCartney M, Goldacre B, Chalmers I, Reynolds C, Mendel J, Smith S, et al. Why the GMC should set up a central registry of doctors’ competing interests. BMJ. 2014 Jan 15;348(jan15 1):g236–g236.
McGettigan P, Pollock AM, Herxheimer A. MPs call for full results of all past clinical trials to be made public. BMJ. 2014 Jan 3;348(jan03 1):g13–g13.